4.7 Article

Myofibroblast activation in colorectal cancer lymph node metastases

Journal

BRITISH JOURNAL OF CANCER
Volume 108, Issue 10, Pages 2106-2115

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2013.209

Keywords

myofibroblasts; colorectal cancer; lymph node; metastases

Categories

Funding

  1. Academic Clinical Lecturer Start Grant from the Academy of Medical Sciences
  2. Wellcome Trust
  3. British Heart Foundation
  4. Arthritis Research UK
  5. KWF Fellowship, The Netherlands
  6. Academy of Medical Sciences (AMS) [AMS-SGCL7-Yeung] Funding Source: researchfish

Ask authors/readers for more resources

Background: Myofibroblasts have an important role in regulating the normal colorectal stem cell niche. While the activation of myofibroblasts in primary colorectal cancers has been previously described, myofibroblast activation in lymph node metastases has not been described before. Methods: Paraffin-embedded lymph node sections from patients with macrometastases, micrometastases and isolated tumour cells were stained to identify myofibroblasts and to characterise the distribution of different cell types in tumour-containing lymph nodes. The extent of myofibroblast presence was quantified and compared with the size of the metastasis and degree of proliferation and differentiation of the cancer cells. Results: We show substantial activation of myofibroblasts in the presence of colorectal metastases in lymph nodes, which is intimately associated with glandular structures, both in micro- and macrometastases. The degree of activation is positively associated with the size of the metastases and the proportion of Ki67 + ve cancer cells, and negatively associated with the degree of enterocyte differentiation as measured by CK20 expression. Conclusion: The substantial activation of myofibroblasts in tumour-containing lymph nodes strongly suggests that these metastatic cancer cells are still significantly dependent on their microenvironment. Further understanding of these epithelial-mesenchymal interactions could lead to the development of new therapies in metastatic disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available